Literature DB >> 5485178

Anticoagulation by ancrod for haemodialysis.

G H Hall, H M Holman, A D Webster.   

Abstract

The defibrinating agent ancrod (Arvin) was used instead of heparin for intermittent haemodialysis. It was an effective, and apparently safe, anticoagulant and reduced the deposition of fibrin and leucocytes on the Cellophane membrane. Administration was more complicated and urea dialysance was less with ancrod than with heparin.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5485178      PMCID: PMC1820166          DOI: 10.1136/bmj.4.5735.591

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  4 in total

1.  Clinical effects of bites by Malayan viper (Ancistrodon rhodostoma).

Authors:  H A REID; P C THEAN; K E CHAN; A R BAHAROM
Journal:  Lancet       Date:  1963-03-23       Impact factor: 79.321

2.  A rapid method of estimating fibrinogen.

Authors:  R M STIRLAND
Journal:  Lancet       Date:  1956-05-12       Impact factor: 79.321

3.  Anticoagulant therapy with a purified fraction of Malayan pit viper venom.

Authors:  A A Sharp; B A Warren; A M Paxton; M J Allington
Journal:  Lancet       Date:  1968-03-09       Impact factor: 79.321

4.  Therapeutic defibrination in the treatment of thrombotic disease.

Authors:  W R Bell; W R Pitney; J F Goodwin
Journal:  Lancet       Date:  1968-03-09       Impact factor: 79.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.